Trial
NCT00995059
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Mayo Clinic
Collaborators
—
Condition
Multiple Myeloma
Intervention
nonmyeloablative allogeneic hematopoietic stem cell transplantation
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-05